Stockholders' Equity Attributable to Parent of VitaNova Life Sciences Corp from 30 Apr 2017 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
VitaNova Life Sciences Corp quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 30 Apr 2017 to 31 Oct 2025.
  • VitaNova Life Sciences Corp Stockholders' Equity Attributable to Parent for the quarter ending 31 Oct 2025 was $1,898,193, a 83% increase year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

VitaNova Life Sciences Corp Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,898,193 +$863,319 +83% 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 $1,862,383 +$860,906 +86% 31 Jul 2025 10-Q 15 Dec 2025 2026 Q2
Q1 2025 $1,908,684 +$852,746 +81% 30 Apr 2025 10-Q 15 Dec 2025 2026 Q2
Q4 2024 $1,108,352 +$237,570 +27% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 $1,034,874 +$1,127,091 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 $1,001,477 +$1,084,939 31 Jul 2024 10-Q 15 Dec 2025 2026 Q2
Q1 2024 $1,055,938 +$1,115,153 30 Apr 2024 10-Q 15 Dec 2025 2026 Q2
Q4 2023 $870,782 +$925,612 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 $92,217 -$61,964 -205% 31 Oct 2023 10-Q 17 Mar 2025 2025 Q3
Q2 2023 $83,462 -$50,608 -154% 31 Jul 2023 10-Q 17 Mar 2025 2025 Q3
Q1 2023 $59,215 -$24,227 -69% 30 Apr 2023 10-K 24 Jul 2025 2025 FY
Q4 2022 $54,830 -$46,649 -570% 31 Jan 2023 10-Q 11 Mar 2024 2024 Q3
Q3 2022 $30,253 -$13,155 -77% 31 Oct 2022 10-Q 11 Mar 2024 2024 Q3
Q2 2022 $32,854 -$747 -2.3% 31 Jul 2022 10-Q 11 Mar 2024 2024 Q3
Q1 2022 $34,988 +$139,682 +80% 30 Apr 2022 10-K 29 Jul 2024 2024 FY
Q4 2021 $8,181 +$140,926 +95% 31 Jan 2022 10-Q 16 Feb 2023 2023 Q3
Q3 2021 $17,098 +$129,110 +88% 31 Oct 2021 10-Q 16 Feb 2023 2023 Q3
Q2 2021 $32,107 +$101,716 +76% 31 Jul 2021 10-Q 16 Feb 2023 2023 Q3
Q1 2021 $174,670 -$52,094 -42% 30 Apr 2021 10-K 15 May 2023 2023 FY
Q4 2020 $149,107 -$56,868 -62% 31 Jan 2021 10-Q 17 Feb 2022 2022 Q3
Q3 2020 $146,208 -$56,563 -63% 31 Oct 2020 10-Q 17 Feb 2022 2022 Q3
Q2 2020 $133,823 -$63,697 -91% 31 Jul 2020 10-Q 17 Feb 2022 2022 Q3
Q1 2020 $122,576 -$72,334 -144% 30 Apr 2020 10-K 16 May 2022 2022 FY
Q4 2019 $92,239 -$55,593 -152% 31 Jan 2020 10-Q 21 Jun 2021 2021 Q3
Q3 2019 $89,645 -$89,695 31 Oct 2019 10-Q 21 Jun 2021 2021 Q3
Q2 2019 $70,126 -$96,455 -366% 31 Jul 2019 10-Q 21 Jun 2021 2021 Q3
Q1 2019 $50,242 -$92,397 -219% 30 Apr 2019 10-K 01 Jul 2021 2021 FY
Q4 2018 $36,646 -$82,996 -179% 31 Jan 2019 10-Q 20 Mar 2020 2020 Q3
Q3 2018 $50* -$59,050 31 Oct 2018 10-Q 20 Mar 2020 2020 Q3
Q2 2018 $26,329 31 Jul 2018 10-Q 06 Dec 2019 2020 Q2
Q1 2018 $42,155 +$45,830 30 Apr 2018 10-K 05 Aug 2020 2020 FY
Q4 2017 $46,350 31 Jan 2018 10-Q 22 Feb 2018 2018 Q3
Q3 2017 $59,100 31 Oct 2017 10-Q 18 Dec 2017 2018 Q2
Q1 2017 $3,675 30 Apr 2017 10-K 30 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.